Back

Betrixaban compared to enoxaparin among obese acute medically ill subjects: an APEX trial subgroup analysis

25 August 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Obesity and cardiovascular disease Obesity ESC Premium Access ESC Congress 2018

About the speaker

Photo
Miss Megan Yee

Boston (United States of America)

8 More presentations in this session

Presentation thumbnail
Obesity, fitness and the risk of incident atrial fibrillation in healthy adults
Doctor A. Younis (Rochester, US)
Abstract Slides Video
Presentation thumbnail
Metabolically healthy obesity is associated with a distinct epicardial fat phenotype and low myocardial oxidative stress
Doctor A. Antonopoulos (Athens, GR)
Abstract
Presentation thumbnail
Epicardial obesity as one of the significant predictors of subclinical multifocal atherosclerosis
Doctor A. Ott (Barnaul, RU)
Abstract Slides Video
Presentation thumbnail
Gender disparities of distribution of epicardial adipose tissue and its impact on coronary artery disease
Doctor G. Maimaituxun (Fukushima, JP)
Abstract Slides Video
Presentation thumbnail
Very low calorie diets lead to temporary and reversible left ventricular impairment
Doctor J. Rayner (Oxford, GB)
Abstract

Access the full session

Session thumbnail
Obesity and cardiovascular disease

The Event

Event poster

ESC Congress 2018

25 August - 29 August 2018
You may be interested in
thumbnail
Congress Presentation
State-of-the-art lecture on obesity and pre-diabetes: where do we stand today on prevention and treatment?
thumbnail
Congress Presentation
Obesity as a disease: focus on the heart
thumbnail
Congress Presentation
Effects of diet and exercise

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources